LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-20
DOI
10.3389/fendo.2018.00167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling
- (2018) Inmaculada Ruz-Maldonado et al. DIABETES OBESITY & METABOLISM
- Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
- (2017) Inigo Ruiz de Azua et al. JOURNAL OF CLINICAL INVESTIGATION
- The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
- (2017) Silvana Y. Romero-Zerbo et al. Scientific Reports
- Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress
- (2016) Shengcun Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men
- (2016) Yuqi Luo et al. MEDICINE
- Effects of Ang II Receptor Blocker Irbesartan on Adipose Tissue Function in Mice with Metabolic Disorders
- (2014) Akinobu Maeda et al. International Journal of Medical Sciences
- Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
- (2014) Un Jung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adipocytokines in obesity and metabolic disease
- (2014) Haiming Cao JOURNAL OF ENDOCRINOLOGY
- Deamidated Lipocalin‐2 Induces Endothelial Dysfunction and Hypertension in Dietary Obese Mice
- (2014) Erfei Song et al. Journal of the American Heart Association
- Adipose Gene Expression Profiles Related to Metabolic Syndrome Using Microarray Analyses in Two Different Models
- (2014) Hye Jin Yoo et al. Diabetes & Metabolism Journal
- C333H Ameliorated Insulin Resistance through Selectively Modulating Peroxisome Proliferator-Activated Receptor γ in Brown Adipose Tissue of db/db Mice
- (2013) Ning Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis
- (2013) Guangyu Wu et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats
- (2013) Wei Chen et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
- (2013) Kengo Azushima et al. PLoS One
- Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: A PET study
- (2013) Akihiro Takano et al. SYNAPSE
- Inflammation and metabolic dysfunction: links to cardiovascular diseases
- (2012) Annika Taube et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The use of animal models in diabetes research
- (2012) Aileen JF King BRITISH JOURNAL OF PHARMACOLOGY
- Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
- (2012) Cristoforo Silvestri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity
- (2012) Q Ge et al. INTERNATIONAL JOURNAL OF OBESITY
- Design and Synthesis of Cannabinoid Receptor 1 Antagonists for Peripheral Selectivity
- (2012) Alan Fulp et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition
- (2011) Jacky TC Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
- (2011) Mónica Alonso et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity
- (2010) I. K.M. Law et al. DIABETES
- P633H, a novel dual agonist at peroxisome proliferator-activated receptors α and γ, with different anti-diabetic effects indb/dband KK-Aymice
- (2009) Wei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans
- (2009) V. Catalán et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice
- (2009) Jogeswar Mohapatra et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines
- (2008) Annette WK Tso et al. Biomarkers in Medicine
- Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice
- (2008) Nigel Irwin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
- (2008) Richard Z. Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH-21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats
- (2008) F. J. Pavón et al. JOURNAL OF NEUROENDOCRINOLOGY
- The Role of Lipocalin 2 in the Regulation of Inflammation in Adipocytes and Macrophages
- (2008) Jinhui Zhang et al. MOLECULAR ENDOCRINOLOGY
- A critical review of the cannabinoid receptor as a drug target for obesity management
- (2008) F. Akbas et al. Obesity Reviews
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started